Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 204

1.

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results.

Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group; Writing Committee:, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd.

Ophthalmology. 2020 Apr;127(4S):S135-S145. doi: 10.1016/j.ophtha.2020.01.029.

PMID:
32200813
2.

Incidence of Macular Atrophy after Untreated Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 40.

Christakis PG, Agrón E, Klein ML, Clemons TE, Campbell JP, Ferris FL, Chew EY, Keenan TD; Age-Related Eye Diseases Study Research Group.

Ophthalmology. 2019 Nov 26. pii: S0161-6420(19)32297-3. doi: 10.1016/j.ophtha.2019.11.016. [Epub ahead of print]

PMID:
31899035
3.

Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.

Domalpally A, Agrón E, Pak JW, Keenan TD, Ferris FL 3rd, Clemons TE, Chew EY.

Ophthalmology. 2019 Dec;126(12):1659-1666. doi: 10.1016/j.ophtha.2019.07.022. Epub 2019 Jul 29.

PMID:
31558345
4.

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned.

Ervin AM, Strauss RW, Ahmed MI, Birch D, Cheetham J, Ferris FL 3rd, Ip MS, Jaffe GJ, Maguire MG, Schönbach EM, Sadda SR, West SK, Scholl HPN; ProgStar Study Group.

Transl Vis Sci Technol. 2019 Apr 12;8(2):16. doi: 10.1167/tvst.8.2.16. eCollection 2019 Apr.

5.

Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39.

Tisdale AK, Agrón E, Sunshine SB, Clemons TE, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study Research Group.

JAMA Ophthalmol. 2019 May 1;137(5):543-550. doi: 10.1001/jamaophthalmol.2019.0292.

6.

Longitudinal Study of Dark Adaptation as a Functional Outcome Measure for Age-Related Macular Degeneration.

Chen KG, Alvarez JA, Yazdanie M, Papudesu C, Wong WT, Wiley HE, Keenan TD, Chew EY, Ferris FL 3rd, Cukras CA.

Ophthalmology. 2019 Jun;126(6):856-865. doi: 10.1016/j.ophtha.2018.09.039. Epub 2018 Sep 29.

PMID:
30278196
7.

Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.

Keenan TD, Agrón E, Domalpally A, Clemons TE, van Asten F, Wong WT, Danis RG, Sadda S, Rosenfeld PJ, Klein ML, Ratnapriya R, Swaroop A, Ferris FL 3rd, Chew EY; AREDS2 Research Group.

Ophthalmology. 2018 Dec;125(12):1913-1928. doi: 10.1016/j.ophtha.2018.05.028. Epub 2018 Jul 27.

8.

Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

Gross JG, Glassman AR, Liu D, Sun JK, Antoszyk AN, Baker CW, Bressler NM, Elman MJ, Ferris FL 3rd, Gardner TW, Jampol LM, Martin DF, Melia M, Stockdale CR, Beck RW; Diabetic Retinopathy Clinical Research Network.

JAMA Ophthalmol. 2018 Oct 1;136(10):1138-1148. doi: 10.1001/jamaophthalmol.2018.3255. Erratum in: JAMA Ophthalmol. 2019 Apr 1;137(4):467.

9.

Public Health Burden and Potential Interventions for Myopia.

Modjtahedi BS, Ferris FL 3rd, Hunter DG, Fong DS.

Ophthalmology. 2018 May;125(5):628-630. doi: 10.1016/j.ophtha.2018.01.033. No abstract available.

PMID:
29681290
10.

Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity.

Allahdina AM, Stetson PF, Vitale S, Wong WT, Chew EY, Ferris FL III, Sieving PA, Cukras C.

Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):1953-1963. doi: 10.1167/iovs.17-22668.

11.

Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Daniel E, Pan W, Ying GS, Kim BJ, Grunwald JE, Ferris FL 3rd, Jaffe GJ, Toth CA, Martin DF, Fine SL, Maguire MG; Comparison of Age-related Macular Degeneration Treatments Trials.

Ophthalmology. 2018 Jul;125(7):1037-1046. doi: 10.1016/j.ophtha.2018.01.004. Epub 2018 Feb 14.

12.

Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Daniel E, Grunwald JE, Kim BJ, Maguire MG, Jaffe GJ, Toth CA, Ferris FL 3rd, Martin DF, Shaffer J, Ying GS; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group.

Ophthalmol Retina. 2017 Jan-Feb;1(1):25-33. doi: 10.1016/j.oret.2016.09.001.

13.

Decreased Visual Function Scores on a Low Luminance Questionnaire Is Associated with Impaired Dark Adaptation.

Yazdanie M, Alvarez J, Agrón E, Wong WT, Wiley HE, Ferris FL 3rd, Chew EY, Cukras C.

Ophthalmology. 2017 Sep;124(9):1332-1339. doi: 10.1016/j.ophtha.2017.05.005. Epub 2017 Jun 8.

PMID:
28602520
14.

Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy.

Gross JG, Glassman AR, Klein MJ, Jampol LM, Ferris FL 3rd, Bressler NM, Beck RW.

JAMA Ophthalmol. 2017 Jun 1;135(6):672-673. doi: 10.1001/jamaophthalmol.2017.0969. No abstract available.

15.

Reply.

Schwartz SG, Flynn HW Jr, Grzybowski A, Relhan N, Ferris FL 3rd.

Ophthalmology. 2017 Apr;124(4):e43-e44. doi: 10.1016/j.ophtha.2016.08.035. No abstract available.

PMID:
28335957
16.

Reply.

Schwartz SG, Flynn HW Jr, Grzybowski A, Relhan N, Ferris FL 3rd.

Ophthalmology. 2017 Mar;124(3):e31. doi: 10.1016/j.ophtha.2016.05.046. No abstract available.

PMID:
28219516
17.

Platform-Independent Cirrus and Spectralis Thickness Measurements in Eyes with Diabetic Macular Edema Using Fully Automated Software.

Willoughby AS, Chiu SJ, Silverman RK, Farsiu S, Bailey C, Wiley HE, Ferris FL 3rd, Jaffe GJ.

Transl Vis Sci Technol. 2017 Feb 7;6(1):9. doi: 10.1167/tvst.6.1.9. eCollection 2017 Feb.

18.

Evaluating Effects of Switching Anti-Vascular Endothelial Growth Factor Drugs for Age-Related Macular Degeneration and Diabetic Macular Edema.

Ferris FL 3rd, Maguire MG, Glassman AR, Ying GS, Martin DF.

JAMA Ophthalmol. 2017 Feb 1;135(2):145-149. doi: 10.1001/jamaophthalmol.2016.4820.

PMID:
28006042
19.

Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop.

Nair P, Aiello LP, Gardner TW, Jampol LM, Ferris FL III.

Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5127-5142. doi: 10.1167/iovs.16-20356. Review. No abstract available.

20.

Preventing Diabetic Retinopathy Progression.

Ferris FL 3rd, Nathan DM.

Ophthalmology. 2016 Sep;123(9):1840-2. doi: 10.1016/j.ophtha.2016.05.039. No abstract available.

PMID:
27549874
21.

Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10.

Vitale S, Clemons TE, Agrón E, Ferris FL 3rd, Domalpally A, Danis RP, Chew EY; Age-Related Eye Disease Study 2 (AREDS2) Research Group.

JAMA Ophthalmol. 2016 Sep 1;134(9):1041-7. doi: 10.1001/jamaophthalmol.2016.2383.

PMID:
27442263
22.

Intracameral Antibiotics and Cataract Surgery: Endophthalmitis Rates, Costs, and Stewardship.

Schwartz SG, Flynn HW Jr, Grzybowski A, Relhan N, Ferris FL 3rd.

Ophthalmology. 2016 Jul;123(7):1411-3. doi: 10.1016/j.ophtha.2016.03.024. No abstract available.

PMID:
27342325
23.

Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.

Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Maguire MG, Martin DF, Ying GS, Jaffe GJ, Daniel E, Grunwald JE, Toth CA, Ferris FL 3rd, Fine SL.

Ophthalmology. 2016 Aug;123(8):1751-1761. doi: 10.1016/j.ophtha.2016.03.045. Epub 2016 May 2.

24.

Age-related macular degeneration in patients with uveitis.

Fox AR, Chew EY, Meyerle C, Vitale S, Ferris FL, Nussenblatt RB, Sen HN.

Br J Ophthalmol. 2017 Mar;101(3):342-347. doi: 10.1136/bjophthalmol-2016-308587. Epub 2016 May 6.

25.

Quantification of Ellipsoid Zone Changes in Retinitis Pigmentosa Using en Face Spectral Domain-Optical Coherence Tomography.

Hariri AH, Zhang HY, Ho A, Francis P, Weleber RG, Birch DG, Ferris FL 3rd, Sadda SR; Trial of Oral Valproic Acid for Retinitis Pigmentosa Group.

JAMA Ophthalmol. 2016 Jun 1;134(6):628-35. doi: 10.1001/jamaophthalmol.2016.0502. Erratum in: JAMA Ophthalmol. 2016 Jul 1;134(7):849.

26.

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.

Wells JA, Glassman AR, Ayala AR, Jampol LM, Bressler NM, Bressler SB, Brucker AJ, Ferris FL, Hampton GR, Jhaveri C, Melia M, Beck RW; Diabetic Retinopathy Clinical Research Network.

Ophthalmology. 2016 Jun;123(6):1351-9. doi: 10.1016/j.ophtha.2016.02.022. Epub 2016 Feb 27.

27.

A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema.

Wiley HE, Thompson DJ, Bailey C, Chew EY, Cukras CA, Jaffe GJ, Lee RW, Loken EK, Meyerle CB, Wong W, Ferris FL 3rd.

Ophthalmology. 2016 Apr;123(4):841-9. doi: 10.1016/j.ophtha.2015.11.021. Epub 2016 Feb 10.

28.

Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema.

Bressler SB, Glassman AR, Almukhtar T, Bressler NM, Ferris FL, Googe JM Jr, Gupta SK, Jampol LM, Melia M, Wells JA 3rd; Diabetic Retinopathy Clinical Research Network.

Am J Ophthalmol. 2016 Apr;164:57-68. doi: 10.1016/j.ajo.2015.12.025. Epub 2016 Jan 21.

29.

Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment.

Bressler SB, Ayala AR, Bressler NM, Melia M, Qin H, Ferris FL 3rd, Flaxel CJ, Friedman SM, Glassman AR, Jampol LM, Rauser ME; Diabetic Retinopathy Clinical Research Network.

JAMA Ophthalmol. 2016 Mar;134(3):278-85. doi: 10.1001/jamaophthalmol.2015.5346.

30.

The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.

AREDS2 Research Group, Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Sperduto RD, Ferris FL 3rd, Chew EY.

Ophthalmology. 2016 Apr;123(4):916-7. doi: 10.1016/j.ophtha.2015.10.040. Epub 2015 Dec 11. No abstract available.

31.

Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.

Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW; Diabetic Retinopathy Clinical Research Network.

JAMA Ophthalmol. 2016 Feb;134(2):127-34. doi: 10.1001/jamaophthalmol.2015.4599. Erratum in: JAMA Ophthalmol. 2016 Apr;134(4):469.

32.

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

Writing Committee for the Diabetic Retinopathy Clinical Research Network, Gross JG, Glassman AR, Jampol LM, Inusah S, Aiello LP, Antoszyk AN, Baker CW, Berger BB, Bressler NM, Browning D, Elman MJ, Ferris FL 3rd, Friedman SM, Marcus DM, Melia M, Stockdale CR, Sun JK, Beck RW.

JAMA. 2015 Nov 24;314(20):2137-2146. doi: 10.1001/jama.2015.15217. Erratum in: JAMA. 2016 Mar 1;315(9):944. JAMA. 2019 Mar 12;321(10):1008.

33.

Longitudinal Study of Age-Related Cataract Using Dynamic Light Scattering: Loss of α-Crystallin Leads to Nuclear Cataract Development.

Datiles MB 3rd, Ansari RR, Yoshida J, Brown H, Zambrano AI, Tian J, Vitale S, Zigler JS Jr, Ferris FL 3rd, West SK, Stark WJ.

Ophthalmology. 2016 Feb;123(2):248-254. doi: 10.1016/j.ophtha.2015.10.007. Epub 2015 Nov 3.

34.

The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.

Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Cukras C, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study 2 Research Group.

Ophthalmology. 2015 Dec;122(12):2490-6. doi: 10.1016/j.ophtha.2015.08.028. Epub 2015 Oct 4.

35.

Image Scaling Difference Between a Confocal Scanning Laser Ophthalmoscope and a Flash Fundus Camera.

Nittala MG, Hariri A, Wong WT, Chew EY, Ferris FL, Sadda SR.

Ophthalmic Surg Lasers Imaging Retina. 2015 Sep;46(8):872-9. doi: 10.3928/23258160-20150909-13.

PMID:
26431304
36.

Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT).

Ying GS, Maguire MG, Daniel E, Ferris FL, Jaffe GJ, Grunwald JE, Toth CA, Huang J, Martin DF; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group.

Ophthalmology. 2015 Dec;122(12):2523-31.e1. doi: 10.1016/j.ophtha.2015.08.015. Epub 2015 Sep 15.

37.

Long-term contributions from the diabetes control and complications trial cohort.

Rand LI, Ferris FL 3rd.

JAMA Ophthalmol. 2015 Oct;133(10):1107-8. doi: 10.1001/jamaophthalmol.2015.2735. No abstract available.

PMID:
26270553
38.

Impairments in Dark Adaptation Are Associated with Age-Related Macular Degeneration Severity and Reticular Pseudodrusen.

Flamendorf J, Agrón E, Wong WT, Thompson D, Wiley HE, Doss EL, Al-Holou S, Ferris FL 3rd, Chew EY, Cukras C.

Ophthalmology. 2015 Oct;122(10):2053-62. doi: 10.1016/j.ophtha.2015.06.023. Epub 2015 Aug 4.

39.

Ebola and the eye.

Jampol LM, Ferris FL 3rd, Bishop RJ.

JAMA Ophthalmol. 2015 Oct;133(10):1105-6. doi: 10.1001/jamaophthalmol.2015.2400. No abstract available.

PMID:
26204253
40.

Inflammatory Mechanisms of Age-related Macular Degeneration.

Knickelbein JE, Chan CC, Sen HN, Ferris FL, Nussenblatt RB.

Int Ophthalmol Clin. 2015 Summer;55(3):63-78. doi: 10.1097/IIO.0000000000000073. Review. No abstract available.

41.

The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37.

Glaser TS, Doss LE, Shih G, Nigam D, Sperduto RD, Ferris FL 3rd, Agrón E, Clemons TE, Chew EY; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2015 Jul;122(7):1471-9. doi: 10.1016/j.ophtha.2015.04.007. Epub 2015 May 9.

42.

The importance of peripheral diabetic retinopathy.

Ferris FL 3rd.

Ophthalmology. 2015 May;122(5):869-70. doi: 10.1016/j.ophtha.2015.02.022. No abstract available.

PMID:
25919777
43.

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW.

N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18.

44.

Changes in lens opacities on the age-related eye disease study grading scale predict progression to cataract surgery and vision loss: age-related eye disease study report no. 34.

Indaram M, Agrón E, Clemons TE, Sperduto RD, Wong WT, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2015 May;122(5):888-96. doi: 10.1016/j.ophtha.2014.12.037. Epub 2015 Feb 11.

45.

Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial.

Petrou PA, Cunningham D, Shimel K, Harrington M, Hammel K, Cukras CA, Ferris FL, Chew EY, Wong WT.

Invest Ophthalmol Vis Sci. 2014 Dec 18;56(1):330-8. doi: 10.1167/iovs.14-15877.

46.

Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration.

Adamus G, Chew EY, Ferris FL, Klein ML.

BMC Ophthalmol. 2014 Dec 8;14:154. doi: 10.1186/1471-2415-14-154.

47.

Subjective and objective screening tests for hydroxychloroquine toxicity.

Cukras C, Huynh N, Vitale S, Wong WT, Ferris FL 3rd, Sieving PA.

Ophthalmology. 2015 Feb;122(2):356-66. doi: 10.1016/j.ophtha.2014.07.056. Epub 2014 Oct 14.

PMID:
25444344
48.

Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).

Altaweel MM, Daniel E, Martin DF, Mittra RA, Grunwald JE, Lai MM, Melamud A, Morse LS, Huang J, Ferris FL 3rd, Fine SL, Maguire MG; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group; Comparison of Age-related Macular Degeneration Treatments Trials CATT Research Group.

Ophthalmology. 2015 Feb;122(2):391-398.e5. doi: 10.1016/j.ophtha.2014.08.020. Epub 2014 Oct 11.

49.

Immune responses in age-related macular degeneration and a possible long-term therapeutic strategy for prevention.

Nussenblatt RB, Lee RW, Chew E, Wei L, Liu B, Sen HN, Dick AD, Ferris FL.

Am J Ophthalmol. 2014 Jul;158(1):5-11.e2. doi: 10.1016/j.ajo.2014.03.014. Epub 2014 Apr 4. Review.

50.

Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.

Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Davis MD, Ferris FL 3rd; Age-Related Eye Disease Study Research Group.

JAMA Ophthalmol. 2014 Mar;132(3):272-7. doi: 10.1001/jamaophthalmol.2013.6636.

PMID:
24385141

Supplemental Content

Loading ...
Support Center